ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,513,000 | +5.0% | 89,692 | +21.6% | 0.24% | -11.4% |
| Q4 2021 | $6,202,000 | +16.9% | 73,756 | +25.4% | 0.27% | +5.0% |
| Q3 2021 | $5,306,000 | +93.8% | 58,829 | +104.9% | 0.26% | +103.1% |
| Q2 2021 | $2,738,000 | +60.8% | 28,711 | +92.0% | 0.13% | +23.1% |
| Q1 2021 | $1,703,000 | +106.9% | 14,955 | +151.5% | 0.10% | +55.2% |
| Q4 2020 | $823,000 | -70.6% | 5,947 | -82.5% | 0.07% | -72.7% |
| Q3 2020 | $2,798,000 | -6.1% | 34,049 | -10.7% | 0.24% | -28.4% |
| Q2 2020 | $2,981,000 | +11.8% | 38,108 | -36.5% | 0.34% | -42.3% |
| Q1 2020 | $2,667,000 | -53.3% | 60,033 | -55.1% | 0.59% | -0.7% |
| Q4 2019 | $5,706,000 | – | 133,601 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |